Update on the initial therapy of multiple myeloma
1From the Princess Margaret Hospital, Toronto, Ontario, Canada.
Summary
Novel agents like thalidomide, bortezomib, and lenalidomide have significantly improved multiple myeloma treatment outcomes for all patient groups, enhancing response rates and progression-free survival.
Area of Science:
- Hematology
- Oncology
- Pharmacology
Background:
- Multiple myeloma management has advanced due to new drug discoveries.
- Novel agents have been integrated into various treatment protocols.
Purpose of the Study:
- To review the impact of novel anti-myeloma agents on patient outcomes.
- To discuss the efficacy and toxicity of new treatment regimens.
Main Methods:
- Analysis of phase III clinical trials.
- Review of treatment strategies for transplant-eligible and elderly patients.
Main Results:
- Bortezomib-based regimens show superior outcomes before autologous stem cell transplant (ASCT).
- Novel agents combined with melphalan plus prednisone (MP) improve response rates and progression-free survival (PFS) in the elderly.
- Post-transplant consolidation and maintenance strategies enhance PFS.
Conclusions:
- Novel agents have transformed multiple myeloma therapy, improving outcomes across patient populations.
- Ongoing research and risk stratification will further refine treatment approaches.
More Related Videos
Related Concept Videos
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...